ATE89002T1 - Porphyrine und arzneimittel zur krebsbehandlung. - Google Patents

Porphyrine und arzneimittel zur krebsbehandlung.

Info

Publication number
ATE89002T1
ATE89002T1 AT89301924T AT89301924T ATE89002T1 AT E89002 T1 ATE89002 T1 AT E89002T1 AT 89301924 T AT89301924 T AT 89301924T AT 89301924 T AT89301924 T AT 89301924T AT E89002 T1 ATE89002 T1 AT E89002T1
Authority
AT
Austria
Prior art keywords
porphyrins
same
compound
compounds
cancer pharmaceuticals
Prior art date
Application number
AT89301924T
Other languages
English (en)
Inventor
Raymond Bonnett
Morris Cyril Berenbaum
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Application granted granted Critical
Publication of ATE89002T1 publication Critical patent/ATE89002T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT89301924T 1988-03-11 1989-02-27 Porphyrine und arzneimittel zur krebsbehandlung. ATE89002T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888805849A GB8805849D0 (en) 1988-03-11 1988-03-11 Porphyrins & cancer treatment
EP89301924A EP0337601B1 (de) 1988-03-11 1989-02-27 Porphyrine und Arzneimittel zur Krebsbehandlung

Publications (1)

Publication Number Publication Date
ATE89002T1 true ATE89002T1 (de) 1993-05-15

Family

ID=10633278

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89301924T ATE89002T1 (de) 1988-03-11 1989-02-27 Porphyrine und arzneimittel zur krebsbehandlung.

Country Status (17)

Country Link
US (1) US4992257A (de)
EP (1) EP0337601B1 (de)
JP (1) JP2785033B2 (de)
KR (1) KR970011392B1 (de)
AT (1) ATE89002T1 (de)
AU (1) AU611774C (de)
BR (1) BR1100662A (de)
CA (1) CA1338737C (de)
DE (2) DE68906301T2 (de)
ES (1) ES2055038T3 (de)
GB (1) GB8805849D0 (de)
HK (1) HK129693A (de)
IE (1) IE63290B1 (de)
LU (1) LU90907I2 (de)
NL (1) NL300089I2 (de)
NZ (1) NZ228225A (de)
ZA (1) ZA891653B (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162519A (en) * 1988-03-11 1992-11-10 Efamol Holdings Plc Porphyrins and cancer treatment
US5219878A (en) * 1990-10-05 1993-06-15 Queen's University Tetrapyrrole hydroxyalkylamide photochemotherapeutic agents
US5262532A (en) * 1991-07-22 1993-11-16 E.R. Squibb & Sons, Inc. Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging
US6362175B1 (en) 1991-09-20 2002-03-26 The Trustees Of The University Of Pennsylvania Porphyrin compounds for imaging tissue oxygen
PL165249B1 (pl) * 1991-10-29 1994-11-30 Wojskowa Akad Tech Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL
DE69327972T2 (de) * 1992-11-20 2000-11-02 Univ British Columbia Vancouve Aktivierung von photoempfindlichen mitteln
US6127356A (en) 1993-10-15 2000-10-03 Duke University Oxidant scavengers
JPH07233065A (ja) 1993-12-27 1995-09-05 Canon Inc ピリリウム塩又はピリリウム類似塩を含む光化学治療薬
GB9408746D0 (en) * 1994-05-03 1994-06-22 Scotia Holdings Plc Tumour locallising photosensitising compounds
WO1996009053A1 (en) * 1994-09-20 1996-03-28 Duke University Oxidoreductase activity of manganic porphyrins
US6176842B1 (en) * 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
US6210356B1 (en) * 1998-08-05 2001-04-03 Ekos Corporation Ultrasound assembly for use with a catheter
ES2249784T3 (es) * 1995-06-07 2006-04-01 Duke University Antioxidantges de oxidantes.
US5877165A (en) * 1995-11-02 1999-03-02 Brookhaven Science Associates Boronated porhyrins and methods for their use
ATE230801T1 (de) 1996-10-03 2003-01-15 Canon Kk Verfahren zur detektion von zielnukleinsäure, verfahren zu ihrer quantifizierung und pyrylium- verbindungen zur chemilumineszenz-analyse
US6582392B1 (en) * 1998-05-01 2003-06-24 Ekos Corporation Ultrasound assembly for use with a catheter
US6676626B1 (en) 1998-05-01 2004-01-13 Ekos Corporation Ultrasound assembly with increased efficacy
AU737650B2 (en) 1997-11-03 2001-08-23 Duke University Substituted porphyrins
DE19814405C2 (de) 1998-03-31 2000-03-02 Schastak Astrid Porphyrine und ihre Verwendung als Photosensitizer
DE69928655T2 (de) 1998-04-24 2006-08-24 Duke University Substituierte porphyrine
AU765509B2 (en) * 1998-08-28 2003-09-18 Destiny Pharma Limited Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them
ATE552260T1 (de) 1999-01-25 2012-04-15 Nat Jewish Health Substituierte porphyrine und deren therapeutische verwendung
US6482943B1 (en) * 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
GB0001455D0 (en) 2000-01-21 2000-03-15 Scotia Holdings Plc Porphyrins and related compounds
US20030050297A1 (en) 2001-01-19 2003-03-13 Crapo James D. Cancer therapy
EP1439842A4 (de) 2001-06-01 2009-09-02 Nat Jewish Med & Res Center Oxidantienfänger zur behandlung von diabetes oder zur verwendung bei der transplantation oder induktion von immuntoleranz
EP1453425B1 (de) 2001-12-03 2006-03-08 Ekos Corporation Katheter mit mehreren ultraschall-abstrahlenden teilen
PT102721B (pt) * 2002-02-01 2011-01-24 Cipan Companhia Industr Prod De Antibioticos S A Compostos macrocíclicos tetrapirrólicos com rendimento quântico de oxigénio singuleto adequado à terapia fotodinâmica e processos para a sua preparação
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
US7485721B2 (en) 2002-06-07 2009-02-03 Duke University Substituted porphyrins
US6921371B2 (en) * 2002-10-14 2005-07-26 Ekos Corporation Ultrasound radiating members for catheter
ITFI20020200A1 (it) * 2002-10-21 2004-04-22 Molteni & C Dei Flii Alitti S P A Societa L Porfirine meso-sostituite.
CA2437638A1 (en) 2003-08-20 2005-02-20 John Robert North Photodynamic therapy
US20050048109A1 (en) * 2003-08-26 2005-03-03 Ceramoptec Industries, Inc. Non-polar photosensitizer formulations for photodynamic therapy
CA2457214A1 (en) 2004-02-06 2005-08-06 Qlt Inc. Photodynamic therapy for the treatment of acne
AU2005251395A1 (en) 2004-06-09 2005-12-22 Qlt Inc. Photodynamic therapy for the treatment of hyperactive sebaceous gland disorders using topically applied hydrophobic green porphyrins
US7825153B2 (en) * 2004-08-16 2010-11-02 Ceramoptec Industries, Inc. Photosensitizer formulations and their use
DE102005015286A1 (de) * 2005-04-04 2006-10-05 Tetrapdt Gmbh Photosensibilisatoren als Arzneimittelträger für lokale Markierung und Therapie von neoplastischem Gewebe
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
US9044568B2 (en) 2007-06-22 2015-06-02 Ekos Corporation Method and apparatus for treatment of intracranial hemorrhages
US20090036952A1 (en) 2007-07-30 2009-02-05 National Yang-Ming University Induction driven light module and use thereof
EP2231024A4 (de) * 2007-12-14 2015-03-18 Ekos Corp Ultraschallpulsformung
JP5608644B2 (ja) 2008-05-23 2014-10-15 ナショナル ジューイッシュ ヘルス アルキル化種の被爆に関連する損傷の処置方法
RU2574062C9 (ru) 2008-09-18 2016-10-27 Биолитек Унтернеменсбетайлигунгс Ii Аг НОВЫЙ СПОСОБ И ПРИМЕНЕНИЕ НЕСИММЕТРИЧНО мезо-ЗАМЕЩЕННЫХ ПОРФИРИНОВ И ХЛОРИНОВ ДЛЯ ФДТ
US9211283B2 (en) 2009-12-11 2015-12-15 Biolitec Pharma Marketing Ltd Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
CA2824768A1 (en) 2011-01-13 2012-07-19 Qlt Inc. Pharmaceutical compositions for topical delivery of photosensitizers and uses thereof
EP2872178A1 (de) 2012-07-11 2015-05-20 Dermira, Inc. Pharmazeutische zusammensetzungen für die topische verabreichung von photosensibilisatoren und ihre verwendung
US9550072B2 (en) 2012-08-03 2017-01-24 Cerca Solutions, LLC Diagnostic device, therapeutic device, and uses thereof
WO2016051361A1 (en) 2014-09-30 2016-04-07 Biolitec Unternehmensbeteiligungs Ii Ag Specifically meso-substituted porphyrins and chlorins for photodynamic therapy
WO2016201136A1 (en) 2015-06-10 2016-12-15 Ekos Corporation Ultrasound catheter
EP3894421A1 (de) 2018-12-10 2021-10-20 Universität Hamburg Spezifisch glyko-substituierte porphyrine und chlorine für fotodynamische therapie
WO2022074014A1 (en) 2020-10-05 2022-04-14 Biolitec Unternehmensbeteiligungs Ii Ag Tetrapyrrole-based compounds and their formulations for anti-microbial therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2740794A (en) * 1954-07-26 1956-04-03 Exxon Research Engineering Co Synthesis of novel vanadium porphyrin
US3076813A (en) * 1957-11-13 1963-02-05 Monsanto Chemicals alpha, beta, gamma, sigma-tetra-arylporphins
US3687863A (en) * 1970-05-25 1972-08-29 Gen Telephone & Elect Optical filters containing tetraphenyl-porphins and method of making same
DE2308252A1 (de) * 1973-02-20 1974-08-22 Basf Ag Verfahren zur herstellung von mesotetraarylporphinen
US4330637A (en) * 1981-01-05 1982-05-18 Western Electric Company, Inc. Encapsulated electronic devices and encapsulating compositions
DE3464252D1 (en) * 1983-06-03 1987-07-23 Hoffmann La Roche Labelled molecules for fluorescence immunoassays and processes and intermediates for their preparation
GB8429845D0 (en) * 1984-11-26 1985-01-03 Efamol Ltd Porphyrins & cancer treatment
GB8522670D0 (en) * 1985-09-13 1985-10-16 Efamol Ltd Drug treatments

Also Published As

Publication number Publication date
CA1338737C (en) 1996-11-26
GB8805849D0 (en) 1988-04-13
NL300089I2 (nl) 2002-08-01
JP2785033B2 (ja) 1998-08-13
NL300089I1 (nl) 2002-07-01
DE68906301D1 (de) 1993-06-09
ES2055038T3 (es) 1994-08-16
IE890687L (en) 1989-09-11
DE10299012I2 (de) 2004-05-06
LU90907I2 (fr) 2003-04-30
BR1100662A (pt) 1999-10-13
KR890014548A (ko) 1989-10-24
JPH01275528A (ja) 1989-11-06
IE63290B1 (en) 1995-04-05
AU3097589A (en) 1989-09-14
AU611774B2 (en) 1991-06-20
US4992257A (en) 1991-02-12
EP0337601B1 (de) 1993-05-05
DE68906301T2 (de) 1993-09-30
HK129693A (en) 1993-12-03
ZA891653B (en) 1989-11-29
NZ228225A (en) 1990-08-28
EP0337601A1 (de) 1989-10-18
AU611774C (en) 2002-02-21
KR970011392B1 (ko) 1997-07-10
DE10299012I1 (de) 2002-07-18

Similar Documents

Publication Publication Date Title
ATE89002T1 (de) Porphyrine und arzneimittel zur krebsbehandlung.
ATE42037T1 (de) Porphyrine und krebsbehandlung.
IN170909B (de)
DE69326369D1 (de) 14-Beta-Hydroxy-10-Deacetyl-Baccatin-III und seine Derivate als Antitumormittel
ATE119774T1 (de) Imidazopyridinderivate und ihre verwendung.
ATE74132T1 (de) Imid-derivate, ihre herstellung und ihre verwendung.
DK0692484T3 (da) Benzothiadiazinderivat, fremgangsmåde til fremstilling deraf samt farmaceutiske sammensætninger indeholdende derivatet
DE69416191D1 (de) Spiropyran-Derivate mit photochromischen Eigenschaften
DK1211250T3 (da) C10-Taxanderivater samt farmaceutiske præparater
DE69228307D1 (de) Imidazo(1,2-c)chinazolinderivate als antihypertensive und antidysurie
DE69419661D1 (de) Thiazolotriazol- und Thiazolodiazolderivate mit fungizider Aktivität
NO895165L (no) Pyrazolopyridin-type mevalono-laktoner.
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
AU6029090A (en) Improvements in or relating to organic compounds